We are live on ! Find out more
AVNR

AVANIR PHARMACEUTICALS, INC CL A
AVNR

Delisted

AVNR was delisted on the 12th of January, 2015.

142 hedge funds and large institutions have $1.93B invested in AVANIR PHARMACEUTICALS, INC CL A in 2014 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 54 increasing their positions, 36 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more funds holding in top 10

Funds holding in top 10: 16 (+5)

405% more call options, than puts

Call options by funds: $152M | Put options by funds: $30M

180% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 15

171% more capital invested

Capital invested by funds: $711M → $1.93B (+$1.22B)

50% more repeat investments, than reductions

Existing positions increased: 54 | Existing positions reduced: 36

23% more funds holding

Funds holding: 115142 (+27)

Holders
142
Holders Change
+27
Holders Change %
+23.48%
% of All Funds
4.12%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.17%
New
42
Increased
54
Reduced
36
Closed
15
Calls
$152M
Puts
$30M
Net Calls
+$122M
Net Calls Change
+$115M
Name Holding Trade Value Shares
Change
Change in
Stake
FSA
76
Franklin Street Advisors
North Carolina
$1.55M
Tudor Investment Corp
77
Tudor Investment Corp
Connecticut
$1.52M +$870K +127,470 New
ACPU
78
Arrowgrass Capital Partners (US)
Delaware
$1.51M +$865K +126,738 New
PP
79
PDT Partners
New York
$1.35M +$478K +70,012 +161%
AIG
80
American International Group
New York
$1.25M +$608 +89 +0.1%
State Board of Administration of Florida Retirement System
81
State Board of Administration of Florida Retirement System
Florida
$1.24M
Bank of America
82
Bank of America
North Carolina
$1.24M +$412K +60,321 +138%
UBS AM
83
UBS AM
Illinois
$1.22M +$19.1K +2,800 +3%
DekaBank Deutsche Girozentrale
84
DekaBank Deutsche Girozentrale
Germany
$1.2M +$58K +8,500 +9%
Janus Henderson Group
85
Janus Henderson Group
United Kingdom
$1.19M +$683K +100,000 New
MCM
86
Moore Capital Management
New York
$1.19M +$683K +100,000 New
OA
87
Omega Advisors
New York
$1.19M +$683K +100,000 New
BA
88
BlackRock Advisors
Delaware
$1.16M +$4.98K +729 +0.8%
VOYA Investment Management
89
VOYA Investment Management
Georgia
$1.15M
BCM
90
Bluefin Capital Management
New York
$1.11M +$636K +93,105 New
CS
91
Credit Suisse
Switzerland
$1.01M -$570K -83,407 -50%
PAM
92
Panagora Asset Management
Massachusetts
$955K -$6.87K -1,006 -1%
AQR Capital Management
93
AQR Capital Management
Connecticut
$927K -$512K -75,000 -49%
Wells Fargo
94
Wells Fargo
California
$914K -$9.83K -1,440 -2%
JT
95
Jump Trading
Illinois
$857K +$491K +71,867 New
HCM
96
Highbridge Capital Management
New York
$811K +$465K +68,039 New
CCI
97
Columbus Circle Investors
$801K -$140K -20,569 -23%
Commonwealth Equity Services
98
Commonwealth Equity Services
Massachusetts
$781K -$17.5K -2,556 -4%
HSBC Holdings
99
HSBC Holdings
United Kingdom
$736K +$594 +87 +0.1%
Renaissance Technologies
100
Renaissance Technologies
New York
$692K +$396K +58,014 New

AVNR Hedge Fund Activity: Q3 2014 in Review

142 of the 3,448 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q3 2014, worth a combined $1.93B — up 171% from $711M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AVNR positions and 15 closed out — a net gain of 27 holders — while 54 added to existing stakes and 36 trimmed.

The largest buyer was Jefferies Group, adding an estimated $49.2M. The largest seller was Ingalls & Snyder LLC, cutting an estimated $49.8M.

  • 142 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q3 2014, up from 115 in Q2 2014.
  • Funds reported $1.93B of AVANIR PHARMACEUTICALS, INC CL A stock for Q3 2014, up 171% quarter-over-quarter.
  • 42 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q3 2014 and 15 closed out, a net change of +27 holders.
  • The largest AVANIR PHARMACEUTICALS, INC CL A buyer in Q3 2014 was Jefferies Group, an estimated $49.2M added.
  • The largest AVANIR PHARMACEUTICALS, INC CL A seller in Q3 2014 was Ingalls & Snyder LLC, an estimated $49.8M sold.

Based on aggregated 13F filings for Q3 2014.